BioHealth News Archive
Johns Hopkins startup gets funding from company turning research into businesses – Technical.ly Baltimore
A company that works to turn intellectual property into businesses is backing a new Johns Hopkins startup developing therapeutics to treat cancer. {iframe}https://technical.ly/baltimore/2018/05/15/johns-hopkins-startup-gets-funding-from-company-turning-research-into-businesses/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=62929174&_hsenc=p2ANqtz-9ZZJCxFQGChrnW5ikBba2Kk6vAL6RgP1XTdBhsQJ2qot0L3ykWQlu4WYImtnVlCUgLTl8h_lF3RME0tHMxtA_vF-wJYw&_hsmi=62929174{/iframe}
Read More
IPO Slowdown Leads Silicon Valley Venture Giant NEA to Sell $1 Billion Worth of Startup Stakes – WSJ
New Enterprise Associates, one of Silicon Valley’s largest venture-capital firms, plans to sell off a big chunk of its startup investments in response to…
Read More
Rexahn Phase 2a Combination Study of RX-3117 and Abraxane® in First-line Metastatic Pancreatic Cancer Patients Advances to Second Stage (NYSE:RNN)
Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical-stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, advances its ongoing Phase 2a study…
Read More
MockV Solutions Announces Collaboration with NIH for Predicting Viral Clearance During Small Scale Bioprocess Development – MockV Solutions
MockV Solutions, Inc. (MockV or the Company), a company developing innovative products to analyze virus clearance during process development, announced today that it will…
Read More
Iowa AgriTech Accelerator announces startups for program’s 2018 cohort – Silicon Prairie News
The Iowa AgriTech Accelerator is a mentor-led accelerator focused on AgTech innovations. The Accelerator is led by innovators and leaders in several areas of…
Read More
Intralytix Acquires Site for New Headquarters
Intralytix, Inc., announced today that it has closed on the acquisition of a 33,000 sq. ft. building in Columbia, Maryland. The facility, located in…
Read More
UMD announces $1.5 billion fundraising campaign that’s halfway complete – The Diamondback
The University of Maryland announced its goal Friday to fundraise $1.5 billion by the end of 2021 for numerous construction projects, scholarship funds and…
Read More
Seoul to spend massive money in biohealth sector – Korea Biomedical Review
The government said Friday it would spend 7.5 trillion won ($7 billion) to support the biohealth sector by 2022 aggressively. The Ministry of Trade,…
Read More
4 States Control 80 Percent of Venture Capital Dollars – MARYLAND ranked 5th
More than half of all venture capital dollars invested in small businesses and startups during the first three months of 2018 went straight into…
Read More
Army Doctors Grew a Soldier a New Ear — On Her Forearm – Time
You’ve heard the cliché about wearing your heart on your sleeve. But a group of Army doctors did one better: They grew a new…
Read More
Johns Hopkins effort to promote economic growth in Baltimore exceeds expectations – Hub
It pays to be a business in Baltimore. That's the message that Johns Hopkins wants proprietors and their patrons to know as part of…
Read More
Medical device inventor Robert E. Fischell gives University of Maryland School of Medicine $20 million to establish center for biomedical innovation – Baltimore Business Journal
Famous local inventor Robert E. Fischell is gifting $20 million to the University of Maryland School of Medicine in support of biomedical research. The gift…
Read More
Japan’s Takeda clinches $62 billion Shire deal as pharma M&A rolls on – Reuters
Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping…
Read More
Traumatic Brain Injury Research by Emmes Corporation, LDS Hospital, Lovelace Biomedical
The Emmes Corporation today announced that scientists and health professionals from the company, LDS Hospital in Salt Lake City, Utah, Lovelace Biomedical Environmental Research…
Read More
Emergent BioSolutions Moves Things Around — The Motley Fool
The first-quarter numbers for Emergent BioSolutions (NYSE:EBS) didn't look too great. In fact, they were arguably ugly. {iframe}https://www.fool.com/investing/2018/05/08/emergent-biosolutions-moves-things-around.aspx{/iframe}
Read More